RADIANCE MEDICAL SYSTEMS FORMS ... - Endologix

FOR FURTHER INFORMATION
CONTACT STEPHEN KROLL, CFO
(949) 457-9546
RADIANCE MEDICAL SYSTEMS FORMS
MANUFACTURING ALLIANCE WITH BEBIG GmbH
FOR VASCULAR BRACHYTHERAPY PRODUCTS
Irvine, CA -- Thursday 5, 1999 -- Radiance Medical Systems, Inc., (NASDAQ:
RADX) today announced that it has formed an alliance with BEBIG GmbH of Germany
for the manufacture and assembly of Radiance coronary and peripheral vascular radiation
delivery products for distribution in European countries.
The Agreements between Radiance and BEBIG provide that Radiance will transfer
the manufacturing technology to BEBIG over the next six to twelve months. At that time,
BEBIG will perform the radioisotope production, final product assembly and logistical
shipment of Radiance’s radioactive products to final hospital customers in Europe.
Radiance will manufacture its products for distribution in the United States and all other
countries.
Radiance will continue to develop all of its own vascular brachytherapy devices, as
well as maintain all responsibilities and rights on a worldwide basis for the marketing and
sales distribution of products to prevent restenosis following interventional therapy for
coronary and peripheral vascular atherosclerosis.
RADIANCE LICENSES PATENT FROM BEBIG
In addition to the manufacturing alliance, Radiance and BEBIG also completed a
licensing agreement providing Radiance with limited rights to utilize a BEBIG controlled
patent for the delivery of radioactive isotopes for the prevention of restenosis. Radiance
believes that obtaining licensing rights to this patent further strengthens its intellectual
property portfolio for catheter-based delivery of radiation for restenosis prevention.
- more -
13700 Alton Parkway, Suite 160 Irvine, CA 92618
ph: 1.800.983.2284 949.457.9546 Fax: 949.457.9561

page 2
Commenting on these agreements, Michael Henson, Radiance Chairman and CEO,
said “BEBIG is a world leader in the manufacture and physical handling and distribution of
radioisotope source devices. We believe that, since European marketing approval will
undoubtedly occur earlier than the U.S. or Japan, forming this alliance now with BEBIG will
accelerate this manufacturing transition process.”
Radiance Medical Systems, Inc., develops site-specific delivery catheters for the
delivery of radiation to prevent restenosis following the interventional treatment of
atherosclerosis. In addition, Radiance markets coronary stents, coronary stent delivery
systems and balloon dilatation catheters for coronary applications.
Except for historical information contained herein, this news release contains forward-looking
statements, the accuracy of which are necessarily subject to risks and uncertainties. Actual results may be
affected by, among other things, risks and uncertainties related to new product development and
introduction cycles, research and development activities, including failure to demonstrate clinical
efficacy, delays by regulatory authorities, scientific and technical advances by third parties, introduction
of competitive products, third party reimbursement and physician training, and other risk factors and
matters set forth in the Company's Annual Report on Form 10-K as amended for the year ended
December 31, 1998 and the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31,
1999.
# # #